Market Snapshot
S&P Futures
3,814.5
Dow Futures
30,961
Nasdaq Futures
11,557.75
Aquestive Therapeutics, Inc. (AQST) stock declined over -1.53% intraday to trade at $0.63 a share on NASDAQ. The stock opened with a loss of -7.35% at $0.64 and touched an intraday high of $0.654, falling -1.56% against the last close of $0.64. The stock went to a low of $0.618 during the session.
Prev. Close
Market Cap
Day Low
Open
Number of Shares
Day High
P/E ratio
EPS (TTM)
Cash Flow per Share
Free Float in %
Book Value
Volume
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
2022-07-01 | $0.64 | $0.654 | $0.618 | $0.63 | 439,500 |
2022-06-30 | $0.68 | $0.68 | $0.626 | $0.64 | 891,700 |
2022-06-29 | $0.73 | $0.73 | $0.67 | $0.688 | 756,300 |
2022-06-28 | $0.755 | $0.76 | $0.72 | $0.732 | 408,900 |
2022-06-27 | $0.785 | $0.79 | $0.722 | $0.749 | 548,800 |
2022-06-24 | $0.774 | $0.79 | $0.7 | $0.74 | 2,408,300 |
2022-06-23 | $0.703 | $0.773 | $0.7 | $0.76 | 893,500 |
2022-06-22 | $0.68 | $0.741 | $0.68 | $0.713 | 921,800 |
2022-06-21 | $0.71 | $0.757 | $0.65 | $0.716 | 1,320,000 |
2022-06-17 | $0.75 | $0.76 | $0.7 | $0.706 | 2,409,000 |
Employees-
Beta3.43
Sales or Revenue50.83 Million
5Y Sales Change-0.40%
Fiscal Year Ends2021-12-30
SectorHealth Care
IndustryPharmaceuticals
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; and Zuplenz, an oral soluble film formulation of ondansetron for the treatment of nausea and vomiting associated with chemotherapy and post-operative recovery. The company's proprietary product candidates comprise Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; and Exservan, an oral soluble film formulation of riluzole for the treatment of amyotrophic lateral sclerosis. Its proprietary pipeline of complex molecule products include AQST-108, a sublingual film formulation of epinephrine for the treatment of anaphylaxis; and AQST-305, a sublingual film formulation of octreotide for the treatment of acromegaly. Further, the company develops KYNMOBI, a sublingual film formulation of apomorphine for the treatment of episodic off-periods in Parkinson's disease. Aquestive Therapeutics, Inc. was incorporated in 2004 and is headquartered in Warren, New Jersey.
Aquestive Therapeutics, Inc. (NASDAQ: AQST) stock price is $0.63 as of the last check on Friday, July 1. During the trading session, AQST stock reached the peak price of $0.654 while $0.618 was the lowest point it dropped to.
The NASDAQ listed AQST is part of Pharmaceuticals industry that operates in the broader Health Care sector. Aquestive Therapeutics, Inc. , a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally.
Mr. Keith J. Kendall
CEO, Pres & Director
Mr. Daniel Barber
Sr. VP & COO
Mr. A. Ernest Toth Jr.
Sr. VP & CFO
Mr. Alexander Mark Schobel
Chief Innovation & Technology Officer
AQST stock traded closed the last session at $0.63, which is $-0.01 or -1.53% lower than its previous close of $0.64. AQST's current trading price is 0.64% lower than its 52-week high of $6.40 where as its distance from 52-week low of 0.63% is -90.16%.
Number of AQST employees currently stands at -. AQST operates from 30 Technology Drive, Warren, NJ 07059, United States.
Official Webiste of $AQST is: https://www.aquestive.com
AQST could be contacted at AQST operates from 30 Technology Drive, Warren, NJ 07059, United States, or at phone #908 941 1900 and can also be accessed through its website.
AQST stock volume for the day was 438,641 shares while in the previous session number of AQST shares traded was 439,500 . The average number of AQST shares traded daily for last 3 months was 717.15 Thousands.
The percentage change in AQST stock occurred in the recent session was -1.53% while the dollar amount for the price change in AQST stock was $-0.01.
In the recent session, the day high for AQST stock was $0.654 while the low for AQST stock touched on the day was $0.618.
The market value of AQST currently stands at 31.4 Million with its latest stock price at $0.63 and 41.47 Million of its shares outstanding.